Haan E A, Jennings I G, Cuello A C, Nakata H, Fujisawa H, Chow C W, Kushinsky R, Brittingham J, Cotton R G
Birth Defects Research Institute, Royal Children's Hospital, Parkville, Australia.
Brain Res. 1987 Nov 17;426(1):19-27. doi: 10.1016/0006-8993(87)90420-3.
A monoclonal antibody, PH8, has been isolated and shown by immunocytochemistry to bind to serotonergic and catecholaminergic neurons in sections of the rat and human brain. In human brain, obtained at autopsy, particular fixation and embedding conditions eliminate the labelling of catecholaminergic neurons while leaving intact the labelling of serotonergic neurons. This property makes the antibody of potential use for structural studies of serotonergic neurons in the normal and diseased human brain. PH8 was raised to pure monkey phenylalanine hydroxylase and has been shown to bind to the 50,000 mol. wt. phenylalanine hydroxylase polypeptide. Immunocytochemical and immunochemical evidence is presented in support of the hypothesis that the labelling of serotonergic and catecholaminergic neurons results from the binding of PH8 to tryptophan and tyrosine hydroxylase, respectively.
一种单克隆抗体PH8已被分离出来,免疫细胞化学显示它能与大鼠和人类大脑切片中的5-羟色胺能和儿茶酚胺能神经元结合。在尸检获得的人类大脑中,特定的固定和包埋条件可消除儿茶酚胺能神经元的标记,而5-羟色胺能神经元的标记保持完整。这一特性使该抗体有可能用于正常和患病人类大脑中5-羟色胺能神经元的结构研究。PH8是针对纯猴苯丙氨酸羟化酶产生的,已证明它能与分子量为50,000的苯丙氨酸羟化酶多肽结合。本文提供了免疫细胞化学和免疫化学证据,以支持以下假说:5-羟色胺能和儿茶酚胺能神经元的标记分别是由于PH8与色氨酸羟化酶和酪氨酸羟化酶结合所致。